Hormones, Volume 142, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including Estrogen receptor binding mechanism with agonist and antagonist, Biomarker Identification of Medullary Thyroid Carcinoma from Gene Expression Profiles Considering without-treatment and with-treatment Studies – A Bioinformatics approach, Exploring the Role of Estrogen and Progestins in Breast Cancer: A Genomic Approach to Diagnosis, Structural insights on ER-alpha, ER-Beta, progesterone and their drug-targets interactions in Breast cancer, The predictive ability of myokines in patients with chronic heart failure, and much more.
Other chapters cover Endogenous and artificial regulators of pituitary glycoprotein hormone receptors, Insight into vitamin D3 action within the ovary - basic and clinical aspects, Hormonal basis of seasonal changes in metabolism, Viral mimicry and endocrine system: Divulging the importance in host-microbiome crosstalk, Recombinant hormones as biopharmaceuticals: past, present and future, Thyroid hormone biosynthesis and its role in brain development and maintenance, and much more.
1. Unlocking Estrogen Receptors: Structural Insights into Agonists and Antagonists for Glioblastoma Therapy Selvaraj Chandrabose Sr., Periyasamy Vijayalakshmi, Asokan Madeshwaran, Vidhya Rekha Umapathy and Rajeshkumar Shanmugam 2. Biomarker Identification of Medullary Thyroid Carcinoma from Gene Expression Profiles Considering without-treatment and with-treatment Studies – A Bioinformatics approach George Priya Doss C 3. Exploring the Role of Estrogen and Progestins in Breast Cancer: A Genomic Approach to Diagnosis George Priya Doss C 4. The predictive ability of myokines in patients with chronic heart failure Alexander E. Berezin 5. Insight into vitamin D3 action within the ovary - basic and clinical aspects Malgorzata Grzesiak, Monika Herian, Kinga Kaminska and Paula Ajersch 6. Hormonal basis of seasonal changes in metabolism Natalia Kuzmenko 7. Viral mimicry and endocrine system: Divulging the importance in host-microbiome crosstalk Vijay Kumar Prajapati 8. Recombinant Hormones as Biopharmaceuticals: Evolution of Biosynthetic Human Insulin and Its Analogues for Diabetes Management Dileep Francis 9. TBC Telma Alexandra Quintela 10. Thyroid hormone biosynthesis and its role in brain development and maintenance Janaina Sena de Souza 11. Hormonal regulation in diabetes: Special emphasis on sex hormones and metabolic traits Ramanathan Gnanasambandan Sr., Harini Ravi, Soumik Das, Devi Rajeswari, Ganesh V, Abbas Alam choudary and Shreya Chakraborty 12. Therapeutic potentials of Glucose-dependent insulinotropic polypeptide (GIP) in T2DM: The past, present, and future Ramanathan Gnanasambandan Sr. 13. A Crosstalk between ‘Osteocyte Lacunal- Canalicular System’ and metabolism Ebtesam Abdullah Al-Suhaimi, Sultan Akhtar, Meneerah Aljafary, Abdelgadir Homeida, Fatima A. Al Hubail, Hussain Alhawaj, Hamad S. Alrumaih, Amira Daghestani, Alanwood Al-buainain and Amer Lardhi
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.
